The impact of the consistency evaluation policy of generic drugs on the integration of innovation chain and industrial chain in the pharmaceutical manufacturing industry.

Xie Y, Zhang W

Open source

DOI
10.3389/fpubh.2026.1791110
Published
2026
Container
Frontiers in public health
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fpubh.2026.1791110,
  title = {The impact of the consistency evaluation policy of generic drugs on the integration of innovation chain and industrial chain in the pharmaceutical manufacturing industry.},
  author = {Xie Y and Zhang W},
  year = {2026},
  journal = {Frontiers in public health},
  doi = {10.3389/fpubh.2026.1791110},
  url = {https://doi.org/10.3389/fpubh.2026.1791110}
}

RIS

TY  - JOUR
TI  - The impact of the consistency evaluation policy of generic drugs on the integration of innovation chain and industrial chain in the pharmaceutical manufacturing industry.
AU  - Xie Y
AU  - Zhang W
PY  - 2026
JO  - Frontiers in public health
DO  - 10.3389/fpubh.2026.1791110
UR  - https://doi.org/10.3389/fpubh.2026.1791110
ER  - 

APA

Y, X., & W, Z. (2026). The impact of the consistency evaluation policy of generic drugs on the integration of innovation chain and industrial chain in the pharmaceutical manufacturing industry.. Frontiers in public health. https://doi.org/10.3389/fpubh.2026.1791110

Source records